Dr. Margaret von Mehren, MD
Claim this profileFox Chase Cancer Center
Studies Soft Tissue Sarcoma
Studies Liposarcoma
12 reported clinical trials
45 drugs studied
Area of expertise
1Soft Tissue Sarcoma
Stage IV
Stage III
RB positive
2Liposarcoma
Stage IV
Stage III
RB positive
Affiliated Hospitals
Clinical Trials Margaret von Mehren, MD is currently running
DCC-3116 + Anticancer Therapies
for Advanced Cancers
This is a Phase 1/2, multicenter, open-label (unless otherwise specified in a combination-specific module) study of DCC-3116 in combination with anticancer therapies. Modules within the master protocol are defined according to different combinations of DCC-3116 with other anticancer agents.
Recruiting1 award Phase 1 & 2
INT230-6
for Soft Tissue Sarcoma
To compare Overall Survival (OS) for INT230-6 vs United States (US) Standard of Care (SOC) in participants with unresectable or metastatic liposarcoma, undifferentiated pleomorphic sarcoma or leiomyosarcoma who have disease progression prior to study enrollment following no more than 2 standard therapies, which must have included an anthracycline-based regimen, unless contraindicated, and then a maximum of 1 additional regimen.
Recruiting2 awards Phase 35 criteria
More about Margaret von Mehren, MD
Clinical Trial Related4 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Margaret von Mehren, MD has experience with
- Cyclophosphamide
- Everolimus
- Ribociclib
- Doxorubicin
- Doxil
- Fludarabine
Breakdown of trials Margaret von Mehren, MD has run
Soft Tissue Sarcoma
Liposarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Margaret von Mehren, MD specialize in?
Margaret von Mehren, MD focuses on Soft Tissue Sarcoma and Liposarcoma. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Margaret von Mehren, MD currently recruiting for clinical trials?
Yes, Margaret von Mehren, MD is currently recruiting for 3 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Margaret von Mehren, MD has studied deeply?
Yes, Margaret von Mehren, MD has studied treatments such as Cyclophosphamide, Everolimus, Ribociclib.
What is the best way to schedule an appointment with Margaret von Mehren, MD?
Apply for one of the trials that Margaret von Mehren, MD is conducting.
What is the office address of Margaret von Mehren, MD?
The office of Margaret von Mehren, MD is located at: Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 United States. This is the address for their practice at the Fox Chase Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.